ClinicalTrials.gg
RecruitingNCT07440316CO-CEALUpdated Feb 27, 2026

Colorado Community Engagement Alliance

An observational study in Mental Health, Hypertension and Diabetes, sponsored by University of Colorado, Denver. Recruiting at 1 site in United States. Open to participants aged 18 Years to 90 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-27.

Primary conditionHypertensionRegistry: Psychological Well-BeingReclassifiedWhy we changed it
Registry
Psychological Well-Being — the first condition term the registry derived for this study.
ClinicalTrials.gg
Hypertension
Why
  1. Psychological Well-Being is a broad heading, used only when no more specific condition is named.
  2. The study's listed conditions name Hypertension.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by University of Colorado, Denver · Observational

How we know

From the registry’s dates

  • Started Nov 2025; still recruiting 11 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,500
Ages
18 Years to 90 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 14 studies in Hypertension by University of Colorado, Denver — 2 open to participants now, 3 under way, none of them phase 3. Hypertension · University of Colorado, Denver.

Started
2025
the only one that year
Observational
2 of 14
1 open now
Registered
14th of 14
by date

Among the 14 studies in Hypertension by University of Colorado, Denver, this one is the only one that started in 2025, is one of 2 observational ones, and was the 14th registered.

Hypertension

6,128 studies on the registry are indexed under Hypertension; 907 are open to participants now.

Browse Hypertension studies →

Open to participants now

2 of the 14 studies in Hypertension by University of Colorado, Denver are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 2 open studies →

Where they have run

Who these studies take

Of the 552 Hypertension studies recruiting now, 260 (47%) set no upper age limit and 198 (36%) stop at 75 or younger; 40 take children under 18; 136 take healthy volunteers.

This study: 18 Years to 90 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 14 studies in Hypertension by University of Colorado, Denver, or all of them as a file.
02

Study summary

The Colorado Community Engagement Alliance (CO-CEAL) is a partnership between the University of Colorado Anschutz Medical Campus, several community-based organizations, and dozens of trusted local community members. Its mission is to address disproportionate impacts on health through active community engagement and outreach, capacity building, and long-lasting community partnerships to improve participation in health research. Funding for CEAL comes from the National Institutes of Health (NIH).

Read the detailed description

CO-CEAL seeks to strengthen the translation of medical knowledge and scientific evidence into sustainable, culturally relevant practices and messages that resonate with communities. The initiative also aims to build capacity among community members and foster partnerships both between communities and the University and within communities themselves.

CO-CEAL uses the Transcreational Framework to engage with 5 communities in urban and rural Colorado to co-identify and co-address chronic disease-related issues with interventions that align with community cultural norms and values. CO-CEAL uses Group Model Building (GMB) to identify leverage points in each community and uses the Boot Camp/Community Translation (BCT) process to transcreate and disseminate messages and interventions related to chronic disease and mental health using a variety of mediums. CO-CEAL collaborates with community members, identified for their status as trusted messengers and having strong community connections, to build networks of community members from various sectors/roles to participate in project activities, including Boot Camp Translation, data collection, and participatory community meetings.

03

Conditions studied

  • Mental Health
  • Hypertension
  • Diabetes

Browse trials for

Keywords

  • Community engaged research
  • Transcreation
  • Boot Camp Translation
  • Chronic disease
  • Systems thinking
04

In context

Hypertension Reclassified

6,128 studies on the registry are indexed under Hypertension; 907 are open to participants now.

This study's planned enrollment of 1,500 is above the median of 352 across 1,166 observational studies indexed under Hypertension.

Browse Hypertension studies →

Lead sponsor

University of Colorado, Denver is the lead sponsor of 1,547 studies on the registry; 318 are open to participants now.

Of its 148 completed or terminated interventional studies of FDA-regulated products, 93 (63%) have results posted.

Compared within Hypertension, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Psychological Well-Being. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Individuals meeting inclusion criteria from 5 regions in Colorado including the: Rural and Urban Latina/o/x communities in the Metro Denver area, Pueblo, and San Luis Valley, Urban American Indian/Alaska Native community in Metro Denver and along the Front Range, Rural East African immigrant community in Greeley and Ft. Morgan, and Urban Black/African American community in Metro Denver.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 18 years of age through 90 years of age
  • All genders
  • Identify as Black/African American, East African, Latina/o/x/Hispanic, American Indian/Alaska Native
  • Live in a participating region (Metro Denver, Pueblo, San Luis Valley, Front Range, Fort Morgan, Greeley)

Exclusion criteria

Exclusion Criteria:

  • Greater than 90 years of age
  • Individuals younger than 18 years of age
  • Individuals not identifying as Black/African American, East African, Latina/o/x/Hispanic, or American Indian/Alaska Native
  • Individuals who do not live in a participating region (Metro Denver, Pueblo, San Luis Valley, Front Range, Fort Morgan, Greeley)
06

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,500 participants (estimated)
Patient registry
No

Groups and cohorts

  • Urban Latina/o/x

    Urban Latina/o/x in Metro Denver and Pueblo

    Behavioral: Individual awareness and focused behavior change

  • Rural Latina/o/x

    Rural Latina/o/x in the San Luis Valley

    Behavioral: Individual awareness and focused behavior change

  • Urban Black/African American

    Urban Black/African American in Metro Denver

    Behavioral: Individual awareness and focused behavior change

  • Rural East African

    Rural East African immigrant in Fort Morgan and Greeley

    Behavioral: Individual awareness and focused behavior change

  • American Indian/Alaska Native

    American Indian/Alaska Native in Metro Denver and Boulder

    Behavioral: Individual awareness and focused behavior change

Interventions

  • BehavioralIndividual awareness and focused behavior change

    Transcreation of existing or new behavioral/knowledge-focused intervention.

07

What researchers measure

Primary outcomes

  1. Change in the number of respondents reporting how many times per week over the past month do they eat a green leafy or lettuce salad, with or without other vegetables as measured by Common Survey 4.

    Response options are on a scale of "Never" to "More than 6 times per week". Change indicates an increase or decrease of the number of times per week a respondent eats leafy greens.

    Time frame: From Baseline Common Survey 4 to Follow-Up Common Survey 4, up to 2 years

  2. Change in the number of respondents reporting a lack of reliable transportation over the past 12 months that keeps them from medical appointments, meetings, work, or getting things they need for daily living as measured by Common Survey 4.

    Response options are "Yes" and "No". Change is indicated by moving from "Yes" to "No" and vice versa; "Yes" indicates respondent does not have reliable transportation for such activities; "No" indicates respondent has reliable transportation for such activities.

    Time frame: From Baseline Common Survey 4 to Follow-Up Common Survey 4, up to 2 years

  3. Change in the number of respondents reporting getting the social and emotional support they need as measured by Common Survey 4.

    Response options are on a scale of "Never" to "Always" to describe how often they receive the social and emotional support they need. Change is indicated by moving from receiving support less frequently to receiving support more frequently (e.g., moving from "Rarely" to "Sometimes").

    Time frame: From Baseline Common Survey 4 to Follow-Up Common Survey 4, up to 2 years

08

Study locations

1 of 1 sites recruiting
09

References and documents

Individual participant data

Plan to share: No — We will share aggregated data.

No publications or documents are linked to this record.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2025 (actual). Primary completion is estimated for Jun 2027, 19 months after the start.

Of 348 non-industry observational studies under Hypertension, half reached primary completion within 44 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 111. This study's planned 19 months is below that.

Counting every sponsor, half of 429 studies reached it within 38 months; a quarter within 17 and three quarters within 96.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 10, 2026
First posted
Feb 27, 2026
StartActual
Nov 23, 2025
Primary completionEst.
Jun 30, 2027
CompletionEst.
Jun 30, 2027
Last update
Feb 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT07440316
Responsible party
Sponsor
First posted
Feb 27, 2026
Start date
Nov 23, 2025
Primary completion
Jun 30, 2027 (estimated)
Completion
Jun 30, 2027 (estimated)
Last update
Feb 27, 2026

Study contacts

Donald Nease, Jr., MD
Contact
donald.nease@cuanschutz.edu
303.724.7283
Montelle Tamez
Contact
montelle.tamez@cuanschutz.edu

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion